Clinical Benefit of Allogeneic Melanoma Cell Lysate-Pulsed Autologous Dendritic Cell Vaccine in MAGE-Positive Colorectal Cancer Patients
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2009-12-15 / Clin. Cancer Res. 2009 Dec;15(24):7726-7736A changing world for DCvax: a PSMA loaded autologous dendritic cell vaccine for prostate cancer
/in International Publications, Prostate Cancer /von 2009-12-01 / Expert Opin Biol Ther 2009 Dec;9(12):1565-75The choice of the antigen in the dendritic cell-based vaccine therapy for prostate cancer
/in Dendritic Cells, International Publications, Prostate Cancer /von 2009-12-01 / Cancer Treat. Rev. 2010 Apr;36(2):131-41Heat shock proteins and immunity: application of hyperthermia for immunomodulation
/in Hyperthermia, International Publications /von 2009-12-01 / Int J Hyperthermia 2009 Dec;25(8):610-6Dendritic cells for active anti-cancer immunotherapy: targeting activation pathways through genetic modification
/in Dendritic Cells, International Publications /von 2009-12-01 / Endocr Metab Immune Disord Drug Targets 2009 Dec;9(4):328-43
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution